The company said, “Outset provided 2026 revenue guidance of $125 million to $130 million, a 5% to 9% increase over $119.5 million in 2025, and non-GAAP gross margin guidance in the low to mid-40% range for the year.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OM:
- OM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Outset Medical Wins FDA Clearance for Next-Gen Tablo System
- Outset Medical says next-generation Tablo platform receives FDA clearance
- Outset Medical Previews 2025 Results and Adds Director
- Outset Medical reports Q4 revenue $28.9M, consensus $26.15M